a biotechnology company specialized in the research, development, production and marketing of biomolecules for the pharmaceutical, veterinary and agrochemical industries. Bioibérica was founded in 1975, in Spain and began to do research to produce Heparin, a biomolecule of great biological and therapeutic value, which is extracted from tissues of animal origin. Gradually, Bioibérica became specialized in the production of heparin and other biomolecules for the pharmaceutical, veterinary and agricultural industry. Now, 20% of the Heparin produced in the world is manufactured by Bioibérica. Over the years, a firm commitment to science and technology has consolidated their leadership as a producer of Glycosaminoglycans, in particular, Chondroitin Sulphate, Hyaluronic Acid and Glucosamine, as well as Heparin. Bioibérica also specialises in other active ingredients such as Amino Acids, characterized Peptides and protein Hydrolysates. Bioibérica has now over 100 products designed to improve human, animal and plant health and are represented in over 65 countries. Bioibérica works on the principle of bringing ideas to life.